21 C.F.R. § 866.5630

Beta -2-microglobulin immunological test system.

Last amended: 2019Year: 2026Length: 95 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 866.5630 (2026)

(a) Identification. A beta -2-microglobulin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques beta -2-microglobulin (a protein molecule) in serum, urine, and other body fluids. Measurement of beta -2-microglobulin aids in the diagnosis of active rheumatoid arthritis and kidney disease. (b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9. [47 FR 50823, Nov. 9, 1982, as amended at 84 FR 71800, Dec. 30, 2019]
Cross-references to the CFR
866.9.
21 C.F.R. § 866.5630: Beta -2-microglobulin immunological test system. | Justis AI